NICE recommend the first therapy to treat epidermolysis bullosa
BACKGROUND Epidermolysis bullosa (EB) is a rare, inherited skin fragility disorder caused by mutations in genes encoding anchoring proteins of the dermal-epidermal junction. Severe forms of EB, such as dystrophic EB (DEB) and junctional EB (JEB), usually present at birth and are therefore often diagnosed soon after birth, or in early childhood. EB manifests with […]